[In-vitro analysis of substances used in pancreozymin substitution therapy].
D000681:Amylases / Q000032:analysis; D001230:Aspergillus / Q000201:enzymology; D001646:Bile / Q000032:analysis; D001963:Bromelains / Q000032:analysis; D002918:Chymotrypsin / Q000032:analysis; D004789:Enzyme Activation; D004798:Enzymes / Q000032:analysis*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008049:Lipase / Q000032:analysis; D010179:Pancreas / Q000201:enzymology*; D010182:Pancreatic Diseases / Q000188:drug therapy*; D010184:Pancreatic Extracts / Q000032:analysis; D010194:Pancreatin / Q000032:analysis; D010447:Peptide Hydrolases / Q000032:analysis; D011506:Proteins / Q000032:analysis; D013270:Stomach; D013997:Time Factors; D014020:Tissue Extracts / Q000032:analysis; D014357:Trypsin / Q000032:analysis
D004798:Enzymes; D010184:Pancreatic Extracts; D011506:Proteins; D014020:Tissue Extracts; D010194:Pancreatin; D001963:Bromelains; D008049:Lipase; D000681:Amylases; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D014357:Trypsin
In-vitro-Analyse der zur Pankreasenzym-Substitutionstherapie angewendeten Substanzen